Molecule Details
| InChIKey | INCAIRNHZBEWOA-UHFFFAOYSA-N |
|---|---|
| Compound Name | 9-Chloro-2-[5-[3-(dimethylamino)propyl]-2-(trifluoromethoxy)anilino]-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione |
| Canonical SMILES | CN(C)CCCc1ccc(OC(F)(F)F)c(Nc2ncc3c(n2)-c2ccc(Cl)cc2NC(=S)C3)c1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.98 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P53350 | PLK1 | Homo sapiens | Human | PF00069 PF00659 | 8.2 | IC50 | ChEMBL |
| P11362 | FGFR1 | Homo sapiens | Human | PF07679 PF00047 PF07714 | 6.7 | pIC50 | TTD_MultiTarget |
| P35968 | KDR | Homo sapiens | Human | PF07679 PF00047 PF13895 PF22971 PF07714 PF21339 PF17988 PF22854 | 6.7 | IC50 | ChEMBL;BindingDB |
| Q02161 | RHD | Homo sapiens | Human | PF00909 | 6.7 | pIC50 | TTD_MultiTarget |
| Q9H4B4 | PLK3 | Homo sapiens | Human | PF00069 PF00659 | 6.6 | IC50 | ChEMBL;BindingDB |